Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers
- PMID: 29156773
- PMCID: PMC5689663
- DOI: 10.18632/oncotarget.20846
Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers
Abstract
Hepatocellular carcinoma (HCC) is the dominant histologic type of primary liver cancer, and hepatitis B virus (HBV) infection is one of the major causes of HCC in the chronic HBV. Our study was investigated the association between the polymorphisms of ACYP2 and MPHOSPH6 genes and the risk of HCC induced by HBV infection. A total of 490 subjects were divided into two groups: 248 HBV patients with HCC (Case group), and 242 HBV patients without HCC (Control group). Unconditional logistic regression analysis was used to evaluate the association. The genetic association analysis revealed variant of rs12621038 in ACYP2 gene had a significant association with increasing the risk of HBV-induced HCC based on the genotype, dominant and additive model (P<0.05). Moreover, our results also showed that minor allele "C" of rs3751862 was prevalent in cases than controls (P<0.05), and rs3751862 significantly increased the risk of HCC in chronic HBV carriers under genotype and dominant model (P<0.05). In addition, the haplotype "T-G-G" in MPHOSPH6 showed a harmful factor for the HBV-induced HCC (P<0.05). The results suggested that ACYP2 and MPHOSPH6 as the plausible candidate genes may predict the risk of HCC after chronic HBV infection in Chinese Han population, and further investigations in studies with a larger sample size and other races are needed to validate our findings. These data provide a theoretical foundation for future studies of this correlation between the polymorphisms of ACYP2 and MPHOSPH6 genes and the HCC in chronic HBV carriers.
Keywords: ACYP2; MPHOSPH6; association analysis; hepatitis B virus (HBV); hepatocellular carcinoma (HCC).
Conflict of interest statement
CONFLICTS OF INTEREST The authors have declared that they have no conflicts of interest.
Figures
Similar articles
-
Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.Infect Genet Evol. 2014 Dec;28:201-9. doi: 10.1016/j.meegid.2014.09.032. Epub 2014 Oct 2. Infect Genet Evol. 2014. PMID: 25281206
-
Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.J Korean Med Sci. 2014 Nov;29(11):1523-7. doi: 10.3346/jkms.2014.29.11.1523. Epub 2014 Nov 4. J Korean Med Sci. 2014. PMID: 25408584 Free PMC article.
-
Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.Int J Immunogenet. 2016 Jun;43(3):151-8. doi: 10.1111/iji.12263. Epub 2016 Apr 28. Int J Immunogenet. 2016. PMID: 27122304
-
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
-
ACPY2 gene polymorphisms on cancer risk: a systematic review and meta-analysis.Nucleosides Nucleotides Nucleic Acids. 2022;41(11):1205-1223. doi: 10.1080/15257770.2022.2096899. Epub 2022 Jul 7. Nucleosides Nucleotides Nucleic Acids. 2022. PMID: 35797106
Cited by
-
Single nucleotide polymorphisms in telomere length-related genes are associated with hepatocellular carcinoma risk in the Chinese Han population.Ther Adv Med Oncol. 2020 Jun 10;12:1758835920933029. doi: 10.1177/1758835920933029. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32577134 Free PMC article.
-
Whole-genome resequencing reveals genetic differentiation and selection signatures among wild, local and commercial duck populations.Anim Biosci. 2025 May;38(5):898-909. doi: 10.5713/ab.24.0643. Epub 2024 Nov 28. Anim Biosci. 2025. PMID: 40336248 Free PMC article.
-
Hepatocellular Carcinoma: A Comprehensive Review.Diseases. 2025 Jul 2;13(7):207. doi: 10.3390/diseases13070207. Diseases. 2025. PMID: 40709997 Free PMC article. Review.
-
Novel ribosome biogenesis-related biomarkers and therapeutic targets identified in psoriasis.Sci Rep. 2025 May 27;15(1):18525. doi: 10.1038/s41598-025-03833-8. Sci Rep. 2025. PMID: 40425712 Free PMC article.
-
A novel lactylation-related gene signature for effectively distinguishing and predicting the prognosis of ovarian cancer.Transl Cancer Res. 2024 May 31;13(5):2497-2508. doi: 10.21037/tcr-24-319. Epub 2024 May 29. Transl Cancer Res. 2024. PMID: 38881917 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. https://doi.org/10.3322/caac.21387. - DOI - PubMed
-
- Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. https://doi.org/10.3322/caac.21338. - DOI - PubMed
-
- Elserag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. https://doi.org/10.1053/j.gastro.2007.04.061. - DOI - PubMed
-
- Altekruse SF, Henley SJ, Cucinelli JE, Mcglynn KA. Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States. Am J Gastroenterol. 2014;109:542–553. https://doi.org/10.1038/ajg.2014.11. - DOI - PMC - PubMed
-
- Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010;30:3–16. https://doi.org/10.1055/s-0030-1247128. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous